TrialPloS one2006

A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.

Claudia Arce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.